About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 112 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 112 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 112 trials

CompletedA Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisStudy Title: A Serologic Study to Correlate b-IFN NAb titers to b-IFN Induced Biomarker Response in Patients with Multiple Sclerosis Objectives: Subjects currently on any of the…NCT00288990·Birmingham, Alabama and 27 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)This is a double-blinded, placebo controlled study of estriol pills versus placebo pills in relapsing remitting multiple sclerosis.NCT00451204·Scottsdale, Arizona and 15 others

TerminatedMaximizing Outcome of Multiple Sclerosis TransplantationRandomized study of autologous un-manipulated peripheral blood hematopoietic stem cell transplant (HSCT) comparing two regimens: (1) cyclophosphamide and rabbit anti-thymoglobulin…NCT03342638·Chicago, Illinois

RecruitingOcrevus Zunovo for MS: Mixed MethodsOcrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods…NCT07710105·Chicago, Illinois

Active not recruitingInternet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple SclerosisWe propose a highly-informed, well-designed randomized controlled trial (RCT) that is critical for providing Class I evidence regarding an Internet-delivered physical activity…NCT04518657·Chicago, Illinois

CompletedThe Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)This is a multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study followed by active treatment, to evaluate the efficacy, safety and…NCT01707992·Cullman, Alabama and 283 others

CompletedMechanism of Action of Ocrelizumab in Multiple SclerosisOcrelizumab is FDA approved for therapy of multiple sclerosis (MS). It depletes B cells and stops MS inflammation.NCT03344094·Chicago, Illinois

CompletedFatigue Management Programs for People With MSThis is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS).NCT03550170·Chicago, Illinois and 2 others

CompletedHome Exercise Intervention in Persons With Multiple SclerosisThe objective of this study is to determine the effect of home-based, aerobic exercise training on subclinical atherosclerosis and mobility disability in persons with Multiple…NCT01824550·Chicago, Illinois

CompletedStudy of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TecfideraThe primary objective of this study is to evaluate whether montelukast can reduce the severity of gastrointestinal (GI) events, measured by the Gastrointestinal Symptom Rating…NCT02410278·Jonesboro, Arkansas and 49 others

CompletedSafety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple SclerosisThe purpose of this study was to determine the dose-response curve for the MRI-based efficacy of BAF312 compared with placebo in patients with Relapsing-Remitting Multiple…NCT00879658·Cullman, Alabama and 71 others

CompletedA Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of DMT.NCT02637856·Cullman, Alabama and 81 others

Active not recruitingRemote Therapeutic Monitoring Exercise TrackingThe purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a…NCT06306768·Chicago, Illinois

CompletedFecal Microbiota Transplantation (FMT) in Multiple SclerosisMultiple sclerosis (MS) is a chronic immune central nervous system (CNS) disease of unknown cause.NCT03975413·Chicago, Illinois

CompletedReal-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)The primary objective of the study is to evaluate relapse activity, as measured by the proportion of participants relapsed at 12 months, in participants with relapsing-remitting…NCT02159573·Birmingham, Alabama and 42 others

Active not recruitingOcrelizumab Discontinuation in Relapsing Multiple SclerosisThis study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS.NCT05285891·New Haven, Connecticut and 12 others

CompletedProspective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With OcrelizumabOpen-label, prospective, single-arm, multi-center study to assess disease activity and biomarker of neuronal damage in minority patients (self-identified Black or African American…NCT04377555·Phoenix, Arizona and 27 others

SuspendedStudy of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesThis study is for people who have multiple sclerosis, acute leukemia (in remission), or long-COVID and a Body Mass Index over 27 and may struggle with cognitive issues such as…NCT06171152·Chicago, Illinois

TerminatedEfficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaThe primary objective was to demonstrate the effect of teriflunomide, in comparison to placebo, on frequency of Multiple Sclerosis (MS) relapses in patients with relapsing forms…NCT01252355·Cullman, Alabama and 184 others

Active not recruitingExercise Training, Cognition, and Mobility in Older Adults With Multiple SclerosisThe overall objective of the proposed randomized controlled (RCT) is to determine the feasibility and efficacy of a 16-week theory-based, remotely-delivered, combined exercise…NCT05930821·Chicago, Illinois

PreviousPage 5 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia